Human Capital Solutions, Inc. and Alatheia US Ltd., a venture of the UK-based Unilever Group, partnered to fill two of Alatheia’s most instrumental positions. These roles will play a pivotal role in achieving the start-up’s business plan. Human Capital Solutions began and completed the two searches in record time, three times faster than the average executive search length. This Unilever venture is producing and selling medical electronic devices that are compatible with MRI machines for neurological research and eventually for clinical applications. This neurological breakthrough will potentially diagnose and help create and customize treatments for neurological maladies, such as epilepsy, sleep disorders, etc. With HCS executive search assistance, Alatheia added to its staff: Steve Sheehan as VP of Sales and Marketing and Kimberley Newman as Director of Engineering and Quality Assurance. Filling these two positions brings Alatheia and the Unilever Group two steps closer to achieving worldwide acknowledgement of this revolutionary new technology.
Resources
Human Capital Solutions, Inc. would like to welcome a new member to our consulting team! Jill Hohwald joins HCS as a recent Graduate of the Cameron School of Business at UNC Wilmington. With a background in Production and Operations Management, she is currently concentrating on establishing high quality systems and standard operating procedures for some of Wilmington’s fastest growing Construction and Real Estate firms. We are eager to see what Jill’s diverse skill set will offer to HCS and Wilmington businesses alike.
Bo Burch, Owner and Chief Principal of Human Capital Solutions, Inc. (HCS) attended and participated in The Coastal Entrepreneurial Development’s 15th annual BioTech Conference, Fusing Science, Technology and Industry Leadership, in Winston Salem on May the 22nd and 23rd. With speakers ranging from Richard Reich, PhD of the NC Dept. of Agriculture to Ira Flatow of NPR’s Talk of the Nation, this conference was an opportunity to enlighten the nearly 850 participants about various aspects of the biotech industry and how it will favorably impact North Carolina, and the world’s future.